Study of Pattern and Distribution of Adverse Drug Reactions in Acute Coronary Syndrome Patients in a Tertiary Care Hospital

Read full text Summarise with VIRAT
Authors: Tanya Thoidingjam, Ramashasthri Akhila, Lahari Vanama
Cited by: 0
References: 11

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Acute coronary syndrome (ACS) requires aggressive pharmacotherapy, which increases the risk of adverse drug reactions (ADRs). Systematic evaluation of ADRs is essential to improve patient safety. Objectives: To study the pattern, distribution, causality, severity, and outcomes of ADRs in ACS patients. Methods: Medical records of 100 ACS patients who developed ADRs were retrospectively reviewed. ADRs were assessed using WHO-UMC causality scale and Hartwig and Siegel severity scale. Descriptive statistics and chisquare test were applied. Results: The mean age was 58.6 ± 11.4 years; males predominated (68%). Antiplatelets (42%) and anticoagulants (26%) were the most common suspected drugs. The most affected system was gastrointestinal (34%) followed by hematological (22%). Majority of ADRs were probable (62%) and moderate in severity (55%). Polypharmacy (>5 drugs) was significantly associated with ADRs (p < 0.01). Conclusion: ADRs are frequent in ACS patients, mainly related to antithrombotic therapy. Active pharmacovigilance and rational prescribing can reduce drug-related morbidity.

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Pharmaceutical Practices and Patient Outcomes Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
01
Publication date
30 January 2026
Language
EN